54.56 0.00 (0.00%)
After hours: 4:40PM EDT
|Bid||54.56 x 1100|
|Ask||54.67 x 900|
|Day's Range||53.55 - 54.69|
|52 Week Range||49.03 - 86.31|
|Beta (3Y Monthly)||0.83|
|PE Ratio (TTM)||10.68|
|Earnings Date||Oct 28, 2019|
|Forward Dividend & Yield||1.83 (3.31%)|
|1y Target Est||57.00|
E-commerce giant Amazon.com, Inc. (NASDAQ: AMZN) is expanding its in-store pickup service Counter, announcing on October 23 that it is partnering with GNC Holdings Inc (NYSE: GNC), Health Mart and Stage Stores Inc (NYSE: SSI). This move will allow consumers access to thousands more Counter locations and comes just months after the online retailer announced its in-store pickup service in 100 Rite Aid Corporation (NYSE: RAD) locations in the U.S.
Walgreens Boots Alliance Inc (NASDAQ: WBA ) is scheduled to announce its fiscal fourth-quarter results on Oct. 28. The company is likely to record a high-single digit decline in fiscal 2019 and its adjusted ...
Walgreens Boots Alliance, Inc. (WBA) today announced that its board of directors has declared a quarterly dividend of 45.75 cents per share, unchanged from the previous quarter and an increase of 4 percent from the year-ago quarter. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 348 straight quarters (more than 87 years) and have raised the dividend for 44 consecutive years. Walgreens Boots Alliance (WBA) is the first global pharmacy-led, health and wellbeing enterprise.
DOW UPDATE Shares of Nike and American Express are retreating Wednesday afternoon, though the Dow Jones Industrial Average remains relatively flat. Shares of Nike (NKE) and American Express (AXP) account for -14% of the blue-chip gauge's intraday losses, as the Dow (DJIA) was most recently trading 3 points, or 0.
Shares of Walgreens Boots Alliance Inc. dropped 1.9% in morning trading Wednesday, after J.P. Morgan analyst Lisa Gill backed away from her bullish stance on the drug store services company, citing drawn out expectations for profit growth and a continued uncertain outlook. Gill lowered her rating to neutral, after being at overweight for at least the past 2 1/2 years, and cut her 12-month price target to $63 from $73. "We find it increasingly difficult to support an [overweight] rating with growth taking longer to realize under the current strategy, limited clarity on the roadmap to improvement and few identifiable near-term catalysts," Gill wrote in a note to clients. "Based on our relative rating methodology, we believe there are better opportunities for upside in other companies within our coverage universe at the current time." At J.P. Morgan, an overweight rating indicates the analyst believes the stock will outperform the average total return of the stocks the analyst covers. The stock has tumbled 20.6% year to date, making it the worst performer among Dow Jones Industrial Average components this year. The Dow has gained 15.0% year to date.
UPS is teaming with CVS Health on a program that will deliver prescriptions and retail products to customers’ homes, the company announced. The logistics company plans to expand its drone subsidiary UPS Flight Forward nationally and partner with several new healthcare and hospital network customers, including the retail pharmacy giant. In addition to CVS, UPS (NYSE: UPS) also will work with AmerisourceBergen (NYSE: ABC) to transport medication, supplies and records to medical campuses across the United States served by the wholesale pharmaceutical distributor and will develop drone delivery services on the hospital campuses of health care provider Kaiser Permanente.
Walt Disney World's Flamingo Crossings town center project has been attracting well-known names in hotels and retail — and now it can add a big drug store to its bragworthy list. A new 12,500-square-foot Walgreens is being planned at the Disney mixed-use project being developed on the corner of Flamingo Crossings Boulevard and Western Way, plans filed with the state showed. The store would be one of the first major retail additions to the project west of the Disney's Animal Kingdom theme park, joining a 248-room Marriott Springhill Suites and the 250-room Marriott TownePlace Suite.
Walgreens announced today a new collaboration with Susan G. Komen and The Leukemia & Lymphoma Society to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years. Through a combination of corporate donations and in-store fundraising, the commitment will enable new research in metastatic breast and pediatric blood cancers, as well as increase access, treatment and support services for those living with these diseases. “At Walgreens, we see the devastating impact of a cancer diagnosis and the challenges people living with cancer and their caregivers face in one of the toughest journeys of their lives,” said Richard Ashworth, Walgreens president of operations.
Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.
FedEx Express (NYSE: FDX) on Friday used an unmanned aerial vehicle instead of a truck for last-mile residential deliveries on behalf of pharmacy retailer Walgreens (NASDAQ: WBA). The Oct. 18 deliveries were made by Wing, a subsidiary of Google parent company Alphabet, in Christianburg, Virginia, under a pilot program authorized by the U.S. Federal Aviation Administration (FAA). Customers in eligible delivery zones can submit drone orders from Walgreens via the Wing mobile app or can opt-in with FedEx to receive qualifying packages via drone.
AmerisourceBergen ,Cardinal Health, McKesson and Teva reached a last-minute settlement in a lawsuit related to the opioid crisis.
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Persistent de-emphasizing of tobacco is hurting growth, which should get reflected in the upcoming quarterly results of Walgreens Boots Alliance (WBA).
Futures are up somewhat in this Monday's pre-market after a sell-off Friday. Much of the sentiment going forward will rely on Q3 results and other news items.
Four major drug companies have reached a deal with a pair of Ohio Counties over allegations they played a major role in fueling the opioid crisis.
Distributors Cardinal Health, McKesson, and AmerisourceBergen, as well as Teva, agreed a settlement worth $260m with two Ohio counties, according to people familiar with the matter. The distributors said they will pay about $215m of the total.
Microsoft (MSFT) partners Nuance Communications (NUAN) to deliver robust conversational AI and ambient intelligence technologies to transform doctor-patient interaction.
Sanofi announced Friday a recall of over-the-counter heartburn medication Zantac in the U.S. and Canada, because of possible contamination with N-nitrosodimethylamine (NDMA), which is believed to cause cancer. The U.S.-listed stock fell 0.9% in morning trading. Sanofi said it was working with health authorities to determine the level and extent of the recall. The recall comes less nearly three weeks after CVS Health Corp. , Walgreens Boots Alliance Inc. and Rite Aid Corp. said they were pulling Zantac from their drugstores' shelves following a Food and Drug Administration warning that the the product could contain low levels of NDMA. "Evaluations are ongoing on both drug substance (active ingredient) and finished drug product," Sanofi said Friday in a statement. "Due to inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products, Sanofi has made the decision to conduct the voluntary recall in the U.S. and Canada as the investigation continues." Sanofi's shares have gained 6.2% year to date, while the SPDR S&P Pharmaceuticals ETF has gained 2.0% and the S&P 500 has climbed 19.5%
WBA is a technical turnaround play as the shares have fallen from $86 in December to an August low of $49. Since the beginning of April, following most of the price damage, the stock has traded sideways as downside momentum has abated. An attempted breakout in September on a big pickup in volume failed as it closed a gap and approached the 200-day average (currently $57). WBA then pulled back to its 50-day and bullishly held. Since October 9, the stock has rebounded once again. If it can clear its 200-day and the recent high at $58, the shares have room to run well into the $60's.
DOW UPDATE Powered by strong returns for shares of UnitedHealth and Walgreens Boots, the Dow Jones Industrial Average is climbing Thursday afternoon. The Dow (DJIA) was most recently trading 74 points (0.
ST. LOUIS and DEERFIELD, Ill. , Oct. 17, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC), Walgreens and RxAdvance today announced a strategic partnership to introduce an innovative model for pharmacy ...
Walgreens Boots Alliance (WBA) closed the most recent trading day at $54.66, moving +0.27% from the previous trading session.
DOW UPDATE The Dow Jones Industrial Average is climbing Wednesday morning with shares of Johnson & Johnson and Dow Inc. leading the way for the blue-chip average. The Dow (DJIA) was most recently trading 4 points, or 0.
Walgreens today announced its first of its kind safe medication disposal kiosk program has collected and safely disposed of more than 885 tons – the combined weight of about 350 pickup trucks – of unwanted prescriptions, including controlled substances and other medications, as of Aug. 31, 2019. Walgreens continues to work with leading health care organizations AmerisourceBergen, Pfizer and Prime Therapeutics to expand its safe medication disposal kiosks across the country.